The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only.

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

PARTNER

watch on-demand

About us

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalised medicine with the first end-to-end scientific and business platform, from research to commercialization.

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,900+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.

Find out more

Watch our video

Medidata Decentralized Clinical Trials Program

Learn more

DECENTRALIZED CLINICAL TRIALS - THE FUTURE OF CLINICAL RESEARCH IS HERE

Decentralized Clinical Trials: the Future of Clinical Research is Here. Read about the changing landscape around DCTs and the types of solutions used to run decentralized clinical trials.

PATIENT INSIGHTS PROGRAM FACT SHEET

Medidata’s Patient Insights program infuses the patient perspective into the software development life cycle. It creates technical solutions that improve the overall patient experience in clinical research operations.
Involving patients in the design of our technology solutions ultimately allows them to have better clinical trial experiences. Now, we are opening up access to our award-winning Patient Centricity by Design process via our Patient Design Studios.